Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial

Author Affiliations

¹Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany;²Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany;³Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany;⁴National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany;⁵Department of Hematology, Cell Therapy, Hemostaseology and Infectiology, Leipzig University Hospital, Leipzig, Germany;⁶Coordination Centre for Clinical Trials, University Hospital Heidelberg, Heidelberg, Germany;⁷Institute for Human Genetics, University of Heidelberg, Heidelberg, Germany;⁸Department of Oncology, Hematology, Immuno-Oncology and Rheumatology, Medizinische Klinik und Poliklinik III, University Hospital Bonn, Bonn, Germany;⁹Department of Hematology, Oncology and Palliative Care, Community Hospital Bielefeld, Bielefeld, Germany;¹⁰Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany;¹¹Department of Hematology and Cellular Therapy, Helios Hospital Berlin-Buch, Berlin, Germany;¹²Department of Hematology, Oncology and Stem Cell Transplantation, Evangelische Kliniken Essen-Mitte, Essen, Germany;¹³Department of Hematology, Oncology and Gastroenterology, Kliniken Maria Hilf GmbH, Mönchengladbach, Germany;¹⁴Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Duesseldorf, Germany;¹⁵Department of Hematology, Oncology and Stem Cell Transplantation, Klinikum Chemnitz GmbH, Chemnitz, Germany;¹⁶Department of Hematology and Oncology, Goethe University, Frankfurt, Germany;¹⁷Department of Hematology and Oncology, Katholisches Krankenhaus Hagen gem. GmbH, Hagen, Germany;¹⁸Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany;¹⁹Internal Medicine III, Charité Campus Benjamin Franklin, Berlin, Germany;²⁰Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany;²¹Department of Hematology, University Hospital Essen, Essen, Germany;²²Department of Hematology, Oncology, Immunology, and Rheumatology, University of Tuebingen, Tuebingen, Germany;²³Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany